Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.52 |
| ▸ | FDPS | P14324 | 6/20 | 0.48 |
| ▸ | LAP3 | P28838 | 2/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1074253 | 0.98 | SMPD1 (0.53) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL3818784 | 0.96 | SMPD1 (0.56) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL3817868 | 0.96 | SMPD1 (0.56) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL30568737 | 0.93 | SMPD1 (0.58) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL3820802 | 0.92 | FDPS (0.48) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL2150273 | 0.91 | SMPD1 (0.47) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL31579020 | 0.90 | SMPD1 (0.57) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL9484993 | 0.88 | SMPD1 (0.60) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL10380826 | 0.88 | SMPD1 (0.60) | SMPD1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL7603727 | 0.88 | SMPD1 (0.55) | SMPD1FDPSLAP3S1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103218-A1 | Surfactant | SURFACTANT SOLUTIONS LIMITED (GB) | 2008-05-01 | — | — | US | disclosed |
| EP-1330433-B1 | SURFACTANT | SURFACTANT TECHNOLOGIES LTD (GB) | 2007-01-24 | — | — | EP | disclosed |
| US-20040127749-A1 | Surfactant | SURFACTANT TECHNOLOGIES LIMITED (GB) | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127749-A1 | Surfactant | NOX1, NOX3, SCO2 | SMPD1 152/4885FDPS 4122/4885LAP3 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.